Evidence-based Training

Author(s):  
Anthony P. DuBose ◽  
Yevgeny Botanov ◽  
Maria V. Navarro-Haro ◽  
Marsha M. Linehan

Evidence-based training is a key component in the dissemination and implementation of evidence-based treatments. Dialectical behaviour therapy (DBT) is a well-established evidence-based treatment for suicidal behaviours and emotion dysregulation. However, after publication of the first DBT clinical trial and treatment text, few routes were available to meet the demand for training outside of the treatment development laboratory. Additionally, due to inconsistent standards and regulations for professional training in evidence-based treatments, few mental health professionals had the opportunity to receive training in DBT. To meet the training needs and maintain fidelity to a resource-intensive evidence-based treatment, a novel model of training was developed. Consequentially, an intensive model of training remains the primary means by which practising professionals are trained in standard DBT. This chapter reviews the development and structure of intensive training in DBT and the evidence for the training model’s effectiveness.

Author(s):  
Anthony P. DuBose ◽  
Yevgeny Botanov ◽  
André Ivanoff

International implementation of dialectical behaviour therapy (DBT) faces many challenges, particularly training therapists across cultures. DBT was born out of necessity to help suicidal individuals suffering from severe emotion dysregulation. Due to a growing popularity of the treatment and rising need for transdiagnostic, evidence-based treatments that target suicidal behaviour, DBT implementation has spread globally. The need for increased international DBT implementation is critical, but implementation efforts require careful examination. Due to the resource-intensive framework of DBT, requiring four modes of treatment, in addition to the multiple strategies required of providers, implementation efforts present novel and significant obstacles to consider. This chapter reviews the history of international DBT implementations and outlines important factors to consider in future implementations. Future implementations will also be strongly influenced by findings from the growing field of dissemination and implementation science.


2019 ◽  
Vol 83 (3) ◽  
pp. 199-204 ◽  
Author(s):  
Michelle A. Patriquin

The goal of this special issue is to highlight innovative evidence-based treatments and conceptualizations of emotion regulation difficulties, social impairment, and anxiety in autism spectrum disorder (ASD). The issue is organized into these three highly linked constructs. Targeting these constructs effectively will help to ensure positive outcomes for youth and adults with ASD. It is clear that continued research is needed that creatively addresses emotion regulation problems, social impairment, and anxiety in ASD.


Author(s):  
Mark A. Frye ◽  
Paul E. Croarkin ◽  
Marin Veldic ◽  
Malik M. Nassan ◽  
Katherine M. Moore ◽  
...  

Despite the predominant illness burden, evidence-based treatment, and by extension regulatory approved, for acute bipolar depression is significantly less than evidence bases in acute mania and maintenance treatment. Complicating this deficit has been persistent use of unimodal antidepressant therapy without clear and convincing benefit. Successful regulatory-approved drug development has focused on atypical antipsychotic therapy. Evidence-based treatments also include lamotrigine and divalproex by meta-analyses and a number of manual-based psychotherapies. In contrast, unimodal antidepressants as a class for bipolar depressed patients as a group appear to provide substantial benefit and may pose risk for mood destabilization. Promising novel and neuromodulatory treatments while encouraging require further systematic investigation. Understanding unimodal antidepressant response and risk patterns in bipolar disorder has immediate clinical implications. Moreover, evidence-based guidelines will need to bridge more individualized or precision-based treatment interventions.


2020 ◽  
pp. 136346152097074
Author(s):  
Kate Ellis ◽  
Laura E. Miller-Graff

Cultural adaptation of evidence-based treatments is a pressing priority for global health, and previous research has informed recommendations for guiding the process of translation and adaptation. As research in the domain of cultural adaptation and evaluation of evidence-based treatments progresses, it is critical that researchers communicate key lessons learned, so that models of adaptation can be continuously refined and reconsidered. The work described in this article aimed to translate and culturally adapt an online intervention to address symptoms of posttraumatic stress—the PTSD Coach Online—for use with young adults in Egypt. The cultural adaptation framework proposed by Bernal and colleagues (1995) was used, and focus groups and interviews with members of the target population, mental health professionals, and service users were conducted. The authors encountered a number of challenges in treatment adaptation that generated important insights for future work. Specifically, this case study highlights the importance of translation teams with diverse backgrounds and experiences, the critical nature of iterative feedback throughout the adaptation process, and the importance of a long time-horizon for optimal adaptation.


2012 ◽  
Vol 29 (2) ◽  
pp. 77-96 ◽  
Author(s):  
Jarrod S. Turner ◽  
David J. Leach

Behavioural Activation (BA) therapy is a stand-alone evidence-based treatment for depression and also is being applied to anxiety with promising outcomes. Essentially, BA involves structured therapy aimed at increasing the amount of activity in a person's daily life, so that he or she comes into contact with sources of positive reinforcement for clinically healthy behaviours. Originally, contemporary BA was developed as a behaviour therapy treatment condition in a study that compared BA to Cognitive Behavioural Therapy (CBT). Over time, many variants of BA have appeared in the published literature, which included techniques that might be viewed as being incompatible with the original intended treatment model and more similar to generic forms of CBT. The purpose of this article is to provide researchers and practitioners with a description of what we consider to be the distinctive and essential elements of BA therapy.


2003 ◽  
Vol 11 (1) ◽  
pp. 29-33 ◽  
Author(s):  
Gavin Andrews ◽  
Mark Oakley-Browne ◽  
David Castle ◽  
Fiona Judd ◽  
Andrew Baillie ◽  
...  

Objective: To provide a summary of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guideline for the treatment of panic disorder and agoraphobia Conclusions: Evidence-based treatments for panic disorder and agoraphobia are now clear. These conditions are chronic and disabling in nature, are complicated by delayed treatment and the presence of other psychiatric conditions, and the presence of severe agoraphobia is a negative prognostic indicator. Choice of therapy will depend on the skill of the therapist in applying psychological treatments as well as the preferences of the patient, but there is a role for both psychological and evidence-based pharmacological approaches. The present article is a summary version of the comprehensive Clinical Practice Guideline (Australian and New Zealand Journal of Psychiatry, 2003) which was developed in accordance with National Health and Medical Research Council (NHMRC) criteria. It provides a two-page desk-top summary for use in clinical practice. Economic evaluation of the available evidence-based treatments showed that at 1 year the cost of cognitive behaviour therapy (CBT) is less than the cost of the average drug therapy (CBT becomes cheaper than paroxetine at 8 months, than clomipramine at 11 months and cheaper than imipramine at 13 months). During the second and subsequent years the superiority of CBT increases whether or not the drugs are continued. Evidence levels for specific treatments are provided in the comprehensive guideline and placed in the context of overall principles of thorough assessment and quality clinical management.


2014 ◽  
Vol 11 (4) ◽  
pp. 229-235 ◽  
Author(s):  
Christine E. Sheffer ◽  
Thomas Payne ◽  
Jamie S. Ostroff ◽  
Denise Jolicoeur ◽  
Michael Steinberg ◽  
...  

Each year, tobacco use causes over 6 million deaths and is responsible for hundreds of billions of dollars in health care and economic costs in the world (WHO, 2011). If current trends continue, tobacco is expected to kill over 1 billion people in the 21st century, making it one of the single greatest causes of preventable death and disease in history (WHO, 2011). Long-term abstinence from tobacco use dramatically improves individuals’ health, reduces the incidence of tobacco-related disease, and is clearly responsible for saving lives (Anthonisen et al., 2005). Most tobacco users express a desire to achieve long-term abstinence from tobacco use and make numerous unsuccessful quit attempts over the course of many years (Borland, Partos, Yong, Cummings, & Hyland, 2012; CDC, 2011). Evidence-based treatments for tobacco use and dependence greatly improve the chances that quit attempts result in long-term abstinence (Chambless & Hollon, 1998; Chambless et al., 1998; Compas, Haaga, Keefe, Leitenberg, & Williams, 1998; Fiore et al., 2008; Zwar et al., 2004). Increasing the availability of high-quality evidence-based treatment for tobacco use and dependence will make it more likely that tobacco users use evidence-based treatments and that quit attempts translate into long-term abstinence. The professionalisation of treatment for tobacco dependence by the development of a rigorous, unified Tobacco Treatment Specialist (TTS) certification process will increase the availability of high-quality evidence-based treatment for tobacco use and dependence for all tobacco users.


Psichologija ◽  
2013 ◽  
Vol 47 ◽  
pp. 102-115 ◽  
Author(s):  
E. Kazlauskas

Straipsnyje analizuojamas psichologinės pagalbos būdų suaugusiems asmenims psichotraumatolo­gijoje veiksmingumas. Įsigilinus į 1998–2012 m. paskelbtas metaanalizes, sistemines apžvalgas, geros praktikos vadovus, daromos išvados, kad daugelis tyrimų patvirtina trumpalaikės į traumą orientuotos kognityviosios elgesio terapijos bei nujautrinimo akių judesiais ir perdirbimo (EMDR) terapijos veiksmin­gumą potrauminio streso sutrikimų turintiems asmenims. Tyrimų rezultatai rodo, kad asmenims iš kar­to po trauminio įvykio nerekomenduojama taikyti formalias psichosocialinės intervencijos procedūras, kaip antai psichologinis susirinkimas (angl. debriefing). Yra mokslinių įrodymų, kad trumpalaikė eklekti­nė terapija (BEPP), internetu teikiamos pagalbos ar virtualios realybės taikymo metodai gali veiksmingai padėti asmenims, kurie turi potrauminio streso sutrikimą. Straipsnyje aptariamos tyrimais paremtų psi­chologinės pagalbos metodų diegimo psichotraumatologijos praktikoje problemos. Pagrindiniai žodžiai: psichologinė trauma, potrauminio streso sutrikimas, pagalbos veiksmingumas.   EFFECTIVE PSYCHOLOGICAL TREATMENTS IN PSYCHOTRAUMATOLOGYEvaldas Kazlauskas SummaryThe present article gives an overview of the psycho­logical treatments of psychological trauma. The article is oriented towards practitioners who want to update their knowledge of the recent developments in psychotraumatology. The research findings, based on meta-analyses and good practice guidelines, are presented and the issues related to the implementation of evidence-based treatments are discussed.The study has shown that the critical stress incident debriefing developed by J. T. Mitchell in 1983 (or psychological debriefing) is not recommended imme­diately after trauma. Metaanalysis (Rose et al., 2003; van Emmeric et al., 2002) revealed no positive long-term effects of debriefing immediately after trauma, with indications of negative outcomes in some studies. Practical guidelines of the International Society of Traumatic Stress Studies, as well as other guidelines do not recommend debriefing as a regular procedure for all survivors. Practical, social or legal assistance provided in an empathic way is recommended during the first month after the trauma. Meta-analytical studies published since 1998 concerning the effectiveness of posttraumatic stress disorder treatments demonstrated the efficacy of trauma-focused cognitive-behavioral therapies (TF-CBT) and eye movement reprocessing and desen­sitization therapy (EMDR). Evidence from studies on the effects of a brief eclectic psychotherapy for posttraumatic stress disorder (BEPP), developed by B. Gersons, internet-based treatments, and virtual reality are promising, and these treatments in the future are possible effective alternatives for TF-CBT and EMDR in evidence-based practice. Psychological treatments should be the first option for the treatment of PTSD, with medication used only when the appro­priate psychological treatments are unavailable or the client prefers medication over psychosocial treatment. While a number of RCT studies have shown the efficacy of TF-CBT and EMDR treatment for PTSD, there is still a gap between research and everyday clinical practice. From the practitioner’s point of view, transfer of manual-based methods from RCT efficacy studies to daily practice is not easy. Clinicians are facing complicated cases, and comorbid disorders are widely prevalent with PTSD. We must also be aware that with the new treatments developed, training of these methods and particularly the availability of sys­tematic supervisions are not always easily accessible; this slows down the dissemination and implementation of evidence-based treatments. Clinicians have to take their own responsibility for selecting what is best for a particular client; however, practitioners also need to make decisions based on what science shows to be the most effective treatment.Key words: psychological trauma, posttraumatic stress disorder, effectiveness of treatment.   o:OfficeDocumentSettings> Veiksmingi psichologinės pagalbos būdai psichotraumatologijoje 


Sign in / Sign up

Export Citation Format

Share Document